Selected research
Industry Research
Drug Consulting Service Industry Research Report 2026
Market perspective
The global Drug Consulting Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Consulting Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Consulting Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Consulting Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Consulting Service include Livingston International Inc., Alacrita Holdings Limited, Victory Packaging, Intertek Group plc, EAS CONSULTING GROUP, Pharmaceutical Development Group, Inc., EAG Laboratories, Aphena Pharma Solutions and Labcorp Drug Development, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Consulting Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Consulting Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Consulting Service Market by Company
Livingston International Inc.
Alacrita Holdings Limited
Victory Packaging
Intertek Group plc
EAS CONSULTING GROUP
Pharmaceutical Development Group, Inc.
EAG Laboratories
Aphena Pharma Solutions
Labcorp Drug Development
Engineering Systems Inc.
Parexel
SGS North America Inc.
ICON plc
Decision Resources Group
Premier Consulting
Copyright Owensboro Health.
Orphan Drug Consulting
Societal CDMO
Drug Consulting Service Segment by Type
R&D Consulting
Test Consulting
Design Consulting
Analysis Consulting
Other
Drug Consulting Service Segment by Application
Nutrition
Cosmetic
Dentistry
Pharmaceutical
Other
Drug Consulting Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Consulting Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Consulting Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Consulting Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Consulting Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Consulting
- Test Consulting
- Design Consulting
- Analysis Consulting
- Other
Applications
- Nutrition
- Cosmetic
- Dentistry
- Pharmaceutical
- Other
Companies covered
- Livingston International Inc.
- Alacrita Holdings Limited
- Victory Packaging
- Intertek Group plc
- EAS CONSULTING GROUP
- Pharmaceutical Development Group, Inc.
- EAG Laboratories
- Aphena Pharma Solutions
- Labcorp Drug Development
- Engineering Systems Inc.
- Parexel
- SGS North America Inc.
- ICON plc
- Decision Resources Group
- Premier Consulting
- Copyright Owensboro Health.
- Orphan Drug Consulting
- Societal CDMO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Consulting Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 R&D Consulting
- 2.2.3 Test Consulting
- 2.2.4 Design Consulting
- 2.2.5 Analysis Consulting
- 2.2.6 Other
- 2.3 Drug Consulting Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Nutrition
- 2.3.3 Cosmetic
- 2.3.4 Dentistry
- 2.3.5 Pharmaceutical
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Drug Consulting Service Breakdown Data by Type
- 3.1 Global Drug Consulting Service Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Consulting Service Forecasted Market Size by Type (2027-2032)
4 Drug Consulting Service Breakdown Data by Application
- 4.1 Global Drug Consulting Service Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Consulting Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Consulting Service Market Perspective (2021-2032)
- 5.2 Global Drug Consulting Service Growth Trends by Region
- 5.2.1 Global Drug Consulting Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Consulting Service Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Consulting Service Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Consulting Service Market Dynamics
- 5.3.1 Drug Consulting Service Industry Trends
- 5.3.2 Drug Consulting Service Market Drivers
- 5.3.3 Drug Consulting Service Market Challenges
- 5.3.4 Drug Consulting Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Consulting Service Players by Revenue
- 6.1.1 Global Top Drug Consulting Service Players by Revenue (2021-2026)
- 6.1.2 Global Drug Consulting Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Consulting Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Consulting Service Head Office and Area Served
- 6.4 Global Drug Consulting Service Players, Product Type & Application
- 6.5 Global Drug Consulting Service Manufacturers Established Date
- 6.6 Global Drug Consulting Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Consulting Service Market Size (2021-2032)
- 7.2 North America Drug Consulting Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Consulting Service Market Size by Country (2021-2026)
- 7.4 North America Drug Consulting Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Consulting Service Market Size (2021-2032)
- 8.2 Europe Drug Consulting Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Consulting Service Market Size by Country (2021-2026)
- 8.4 Europe Drug Consulting Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Consulting Service Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Consulting Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Consulting Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Consulting Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Consulting Service Market Size (2021-2032)
- 10.2 South America Drug Consulting Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Consulting Service Market Size by Country (2021-2026)
- 10.4 South America Drug Consulting Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Consulting Service Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Consulting Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Consulting Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Consulting Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Livingston International Inc.
- 12.1.1 Livingston International Inc. Company Information
- 12.1.2 Livingston International Inc. Business Overview
- 12.1.3 Livingston International Inc. Revenue in Drug Consulting Service Business (2021-2026)
- 12.1.4 Livingston International Inc. Drug Consulting Service Product Portfolio
- 12.1.5 Livingston International Inc. Recent Developments
- 12.2 Alacrita Holdings Limited
- 12.2.1 Alacrita Holdings Limited Company Information
- 12.2.2 Alacrita Holdings Limited Business Overview
- 12.2.3 Alacrita Holdings Limited Revenue in Drug Consulting Service Business (2021-2026)
- 12.2.4 Alacrita Holdings Limited Drug Consulting Service Product Portfolio
- 12.2.5 Alacrita Holdings Limited Recent Developments
- 12.3 Victory Packaging
- 12.3.1 Victory Packaging Company Information
- 12.3.2 Victory Packaging Business Overview
- 12.3.3 Victory Packaging Revenue in Drug Consulting Service Business (2021-2026)
- 12.3.4 Victory Packaging Drug Consulting Service Product Portfolio
- 12.3.5 Victory Packaging Recent Developments
- 12.4 Intertek Group plc
- 12.4.1 Intertek Group plc Company Information
- 12.4.2 Intertek Group plc Business Overview
- 12.4.3 Intertek Group plc Revenue in Drug Consulting Service Business (2021-2026)
- 12.4.4 Intertek Group plc Drug Consulting Service Product Portfolio
- 12.4.5 Intertek Group plc Recent Developments
- 12.5 EAS CONSULTING GROUP
- 12.5.1 EAS CONSULTING GROUP Company Information
- 12.5.2 EAS CONSULTING GROUP Business Overview
- 12.5.3 EAS CONSULTING GROUP Revenue in Drug Consulting Service Business (2021-2026)
- 12.5.4 EAS CONSULTING GROUP Drug Consulting Service Product Portfolio
- 12.5.5 EAS CONSULTING GROUP Recent Developments
- 12.6 Pharmaceutical Development Group, Inc.
- 12.6.1 Pharmaceutical Development Group, Inc. Company Information
- 12.6.2 Pharmaceutical Development Group, Inc. Business Overview
- 12.6.3 Pharmaceutical Development Group, Inc. Revenue in Drug Consulting Service Business (2021-2026)
- 12.6.4 Pharmaceutical Development Group, Inc. Drug Consulting Service Product Portfolio
- 12.6.5 Pharmaceutical Development Group, Inc. Recent Developments
- 12.7 EAG Laboratories
- 12.7.1 EAG Laboratories Company Information
- 12.7.2 EAG Laboratories Business Overview
- 12.7.3 EAG Laboratories Revenue in Drug Consulting Service Business (2021-2026)
- 12.7.4 EAG Laboratories Drug Consulting Service Product Portfolio
- 12.7.5 EAG Laboratories Recent Developments
- 12.8 Aphena Pharma Solutions
- 12.8.1 Aphena Pharma Solutions Company Information
- 12.8.2 Aphena Pharma Solutions Business Overview
- 12.8.3 Aphena Pharma Solutions Revenue in Drug Consulting Service Business (2021-2026)
- 12.8.4 Aphena Pharma Solutions Drug Consulting Service Product Portfolio
- 12.8.5 Aphena Pharma Solutions Recent Developments
- 12.9 Labcorp Drug Development
- 12.9.1 Labcorp Drug Development Company Information
- 12.9.2 Labcorp Drug Development Business Overview
- 12.9.3 Labcorp Drug Development Revenue in Drug Consulting Service Business (2021-2026)
- 12.9.4 Labcorp Drug Development Drug Consulting Service Product Portfolio
- 12.9.5 Labcorp Drug Development Recent Developments
- 12.10 Engineering Systems Inc.
- 12.10.1 Engineering Systems Inc. Company Information
- 12.10.2 Engineering Systems Inc. Business Overview
- 12.10.3 Engineering Systems Inc. Revenue in Drug Consulting Service Business (2021-2026)
- 12.10.4 Engineering Systems Inc. Drug Consulting Service Product Portfolio
- 12.10.5 Engineering Systems Inc. Recent Developments
- 12.11 Parexel
- 12.11.1 Parexel Company Information
- 12.11.2 Parexel Business Overview
- 12.11.3 Parexel Revenue in Drug Consulting Service Business (2021-2026)
- 12.11.4 Parexel Drug Consulting Service Product Portfolio
- 12.11.5 Parexel Recent Developments
- 12.12 SGS North America Inc.
- 12.12.1 SGS North America Inc. Company Information
- 12.12.2 SGS North America Inc. Business Overview
- 12.12.3 SGS North America Inc. Revenue in Drug Consulting Service Business (2021-2026)
- 12.12.4 SGS North America Inc. Drug Consulting Service Product Portfolio
- 12.12.5 SGS North America Inc. Recent Developments
- 12.13 ICON plc
- 12.13.1 ICON plc Company Information
- 12.13.2 ICON plc Business Overview
- 12.13.3 ICON plc Revenue in Drug Consulting Service Business (2021-2026)
- 12.13.4 ICON plc Drug Consulting Service Product Portfolio
- 12.13.5 ICON plc Recent Developments
- 12.14 Decision Resources Group
- 12.14.1 Decision Resources Group Company Information
- 12.14.2 Decision Resources Group Business Overview
- 12.14.3 Decision Resources Group Revenue in Drug Consulting Service Business (2021-2026)
- 12.14.4 Decision Resources Group Drug Consulting Service Product Portfolio
- 12.14.5 Decision Resources Group Recent Developments
- 12.15 Premier Consulting
- 12.15.1 Premier Consulting Company Information
- 12.15.2 Premier Consulting Business Overview
- 12.15.3 Premier Consulting Revenue in Drug Consulting Service Business (2021-2026)
- 12.15.4 Premier Consulting Drug Consulting Service Product Portfolio
- 12.15.5 Premier Consulting Recent Developments
- 12.16 Copyright Owensboro Health.
- 12.16.1 Copyright Owensboro Health. Company Information
- 12.16.2 Copyright Owensboro Health. Business Overview
- 12.16.3 Copyright Owensboro Health. Revenue in Drug Consulting Service Business (2021-2026)
- 12.16.4 Copyright Owensboro Health. Drug Consulting Service Product Portfolio
- 12.16.5 Copyright Owensboro Health. Recent Developments
- 12.17 Orphan Drug Consulting
- 12.17.1 Orphan Drug Consulting Company Information
- 12.17.2 Orphan Drug Consulting Business Overview
- 12.17.3 Orphan Drug Consulting Revenue in Drug Consulting Service Business (2021-2026)
- 12.17.4 Orphan Drug Consulting Drug Consulting Service Product Portfolio
- 12.17.5 Orphan Drug Consulting Recent Developments
- 12.18 Societal CDMO
- 12.18.1 Societal CDMO Company Information
- 12.18.2 Societal CDMO Business Overview
- 12.18.3 Societal CDMO Revenue in Drug Consulting Service Business (2021-2026)
- 12.18.4 Societal CDMO Drug Consulting Service Product Portfolio
- 12.18.5 Societal CDMO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst